医療薬学
Online ISSN : 1882-1499
Print ISSN : 1346-342X
ISSN-L : 1346-342X
ノート
ガラスアンプル抗がん剤調製時のガラス粒子の混入と防止に関する研究
小林 由佳岩根 裕紀野崎 歩濱谷 麻衣日置 三紀近藤 絢子石井 一成中西 弘和
著者情報
ジャーナル フリー

2009 年 35 巻 2 号 p. 136-140

詳細
抄録

The contamination of intravenous admixtures by glass particles arising from glass ampoules containing ingredients used in their preparation is The contamination of intravenous admixtures by glass particles arising from glass ampoules containing ingredients used in their preparation is now recognized as a potential health hazard.Previously studies have been done on changes with time in the size of glass particles and particle counts but there are shortcomings in the light obscuration or Coulter-based methods that were used.For instance,the necessity of having particles flowing for the counters used in these methods to count them has been controversial.In this study,therefore,we used a laser diffraction particle size analyzer (LDPSA) to determine glass particle size ranges and counts over a period of 15 minutes following the opening of ampoules.Fourteen ampoules containing 5-fluorouracil (anti-cancer drug) were studied in four experiments.At 15 minutes,the counts/1 A (5 mL) (mean±SD) for each of the size ranges indicated were 4,630±3,070 (0.5 to 2μm),8,860±2,590 (2 to 3μm),3,960± 1,360 (3 to 5μm),950±550 (5 to 7μm),510±200 (7 to 10μm),225±94 (10 to 15μm) and 64±55 (15 to 50μm).These results were confirmed by visual inspection and counting glass particles for the same samples using scanning electron microscopy.Further,the use of these techniques for samples after they had been passed through either a 0.45 or 0.8μm syringe filter failed to show any measureable levels of glass particles in the filtrate.Our results show that glass particles remain suspended for 15 minutes after opening glass ampoules and suggest that the use of syringe filters may reduce glass particle-associated risks in the intravenous administration of admixtures.

著者関連情報
© 2009 日本医療薬学会
前の記事 次の記事
feedback
Top